Dr. B. Borooah Cancer Institute (Regional Cancer Centre), Guwahati

Dr. B. Borooah Cancer Institute (Regional Cancer Centre), Guwahati

Dr. B. Borooah Cancer Institute (Regional Cancer Centre), Guwahati

Dr. Bhubaneswar Borooah Cancer Institute (BBCI) was set up by a voluntary organization called 'Dr. B. Borooah Cancer Society Trust'. Dr. Bhubaneswar Borooah (4th September 1893 - 25th September 1956) was a great physician, freedom fighter and philanthropist of Assam. In 1958 at a public meeting in Guwahati, a decision was taken to set up a cancer hospital at Guwahati to commemorate the memory of Dr. Bhubaneswar Borooah. Late Debendra Nath Sarma was the Founder President and Late Dr. Kanak Chandra Borooah, illustrious brother of Dr. Bhubaneswar Borooah was the Founder Secretary. Late Bimala Prasad Chaliha, Mahendra Mohan Choudhury, Bishnuram Medhi, Dr. Ghanashyam Das, Dr Birendra Nath Choudhury and many others worked relentlessly for the development of the Institute since its inception.

The Institute was formally inaugurated on 18th November 1973 and became operational from 1974. The Institute was recognized as Regional Cancer Centre by the Ministry of Health & Family Welfare, Govt. of India in the year 1980. On 6th of August, 1986 the Institute was handed over to the Government of Assam by the B Borooah Cancer Society Trust retaining its autonomy. The First Tripartite Agreement for revitalization of the Institute involving the North Eastern Council, Government of Assam and the Department of Atomic Energy, Govt. of India became operational from November 1989. This tripartite arrangement for funding and management of the Institute continued till 2017. On the request of the then Chief Minister of Assam Shri Tarun Gogoi and the present Chief Minister of Assam Shri Sarbananda Sonowal, the Cabinet Committee on Security under the Chairmanship of the Hon’ble Prime Minister of India Shri Narendra Modi on 7th of June 2017 approved taking over of Dr B Borooah Cancer Institute, Guwahati by Department of Atomic Energy, Govt. of India as Grant-in-Aid Institute and as a unit of Tata Memorial Centre (Mumbai). The Institute was formally taken over by Department of Atomic Energy, Govt. of India on 27th November 2017 as a unit of Tata Memorial Centre, Mumbai.

The Institute is located at Gopinath Nagar, Guwahati, Assam in a plot of land covering an area of 14.2 acres (43 bighas). About 12,000 new and 80,000 old cancer patients visit the Institute every year. It is a 230-bedded Hospital at present. There are 100 bedded (general) and one 27 bedded executive guest houses for patients & relatives inside the hospital premises. The Institute also has residential campus for the employees. The Institute has started private OPD from 1st January 2017.

A DBT Centre for Molecular Biology and Cancer Research was started in February 2010. The Institute has Population and Hospital Based Cancer Registry under National Cancer Registry Programme of Indian Council of Medical Research. It is involved in many research projects at present.

The Institute conducts MD in Radiotherapy, M.Ch in Surgical Oncology, DM in Medical Oncology, 2 Years Post Graduate Fellowship Programme in Head & Neck Oncology, Gynaecologic Oncology, Surgical Oncology, Medical Oncology and Onco-Pathology in collaboration with Tata Memorial Hospital, Mumbai, Ph.D, M.Sc in Radiological Physics and many other paramedical courses are conducted by BBCI which are affiliated to Srimanta Sankardeva University of Health Sciences, Assam and Gauhati University.

For clinical, academic and research collaboration, Dr. B. Borooah Cancer Institute has signed memorandum of understanding with the Dutch School of Gynaecologic Oncology and Pelvic Surgery, Netherlands, Manitoba University, Canada, Amrita Institute of Medical Sciences, Kochi, Indo-American Cancer Institute, Hyderabad, Institute of Advance Study in Science & Technology, Assam Down Town University. The Institute has more than 200 research publications in national and international journals. The Institute has residential accommodation for employees and hostel for post graduate students. It also has a digital library.

The Department of Radiotherapy has 4 linear accelerators with IMRT, IGRT, VMAT, 6FFF, SRS/SRT, 1 conventional and 1 CT Simulator, 1 HDR Brachytherapy and 3 Computerised Treatment Planning Systems. The Department of Radio-diagnosis has one 64 slice CT Scan, 1.5 Tesla MRI, mammography, Digital X-ray, C-Arm X-ray, Computerised Radiography System, PACS, 2 high-end ultrasound and 1 RFA. The Department of Nuclear Medicine and Molecular Imaging has 1 dual head Spect Gamma Camera machine and 3-bedded high-dose radio-isotope therapy ward. The Institute has well equipped Pathology laboratory with facilities for frozen section, immunohistochemistry, immune diagnostic system and blood bank with component separation. The Surgical Oncology Department is well equipped with 5 modern operation theatres with laser surgery, operative micro surgery, CUSA and other facilities. There is a 26 bedded day care chemotherapy ward in addition to indoor beds. The Institute is soon going to acquire a PET-CT facility.

The Institute has a Palliative Medicine and Preventive Oncology department. Various recreational programmes like sight-seeing, musical & cultural programmes, meditation and yoga are regularly conducted by BBCI. Home Care service for terminally ill cancers in the city of Guwahati was introduced in the year 2017. All the OPD patients are provided free lunch under ANNAKUT scheme. There are provision for free treatment to poor cancer patients under various schemes of Govt. of Assam and Govt. of India.

The Institute in collaboration with St. Jude’s India is going to start a home for paediatric cancer patients from November 2018. M.Sc in Cancer Biology and one year Diploma in Oncology Nursing will be started from the Academic Session 2018. A new pharmacy with highly subsidised medicine will be started soon.

Management
Address
Dr. B. Borooah Cancer Institute, P.O. Gopinath Nagar, A K Azad Road
District
State
Pin
781016
Contact
0361-2472366,2472364
Fax
0361-247263
Contact Directory

a grant-in-aid institute of Department of Atomic Energy,
Govt. of India and a unit of Tata Memorial Centre (Mumbai)
Gopinath Nagar, A K Azad Road, Guwahati-781016,
Assam, India

Phone : 09957033199 / 09957033212
Fax : (91) 0361 – 2472636
E-mail : [email protected]
website : www.bbcionline.org

Course

DM - Onco Pathology

Absolutely, let's delve into Oncopathology. Oncopathology, also known as Surgical Pathology or Anatomic Pathology, is a branch of pathology that deals with the study and diagnosis of cancer. Oncopathologists analyze tissues obtained from biopsies or surgical procedures to determine the nature and characteristics of tumors. Here are key aspects of Oncopathology:

  1. Tissue Examination:

    • Oncopathologists examine tissue samples under the microscope to identify and characterize tumors. This involves studying the architecture of cells, their growth patterns, and other morphological features.
  2. Tumor Grading and Staging:

    • Oncopathologists grade tumors to assess their level of differentiation (how closely the cells resemble normal cells). Staging involves determining the extent of spread and involvement of nearby structures.
  3. Cancer Diagnosis:

    • Oncopathologists provide a definitive diagnosis of cancer, specifying the type of cancer, its grade, and stage. This information is crucial for treatment planning.
  4. Molecular Pathology:

    • Molecular techniques are used to identify specific genetic and molecular alterations in cancer cells. This information helps in predicting the behavior of the tumor and guiding targeted therapies.
  5. Immunohistochemistry (IHC):

    • IHC is a technique that uses antibodies to detect specific proteins in tissue samples. It helps in identifying the cell type and confirming the diagnosis.
  6. Fluorescence In Situ Hybridization (FISH):

    • FISH is a molecular technique used to detect and visualize specific DNA sequences. It is often employed to identify genetic abnormalities associated with certain cancers.
  7. Tumor Biomarkers:

    • Oncopathologists look for specific biomarkers, such as hormone receptors or certain proteins, which can provide information about the tumor's behavior and response to treatment.
  8. Liquid Biopsy:

    • Liquid biopsy involves analyzing components like circulating tumor cells (CTCs) or cell-free DNA in the blood. This technique aids in monitoring treatment response and detecting minimal residual disease.
  9. Multidisciplinary Collaboration:

    • Oncopathologists work closely with oncologists, surgeons, radiologists, and other specialists in a multidisciplinary approach to cancer care.
  10. Cytology:

    • In addition to solid tissue samples, Oncopathologists may analyze cells obtained through fine-needle aspiration (FNA) or other cytological techniques.
  11. Autopsy Pathology:

    • Autopsy studies are conducted to understand the extent and nature of disease in deceased individuals, contributing to medical knowledge and research.
  12. Prognostic and Predictive Factors:

    • Oncopathologists provide information on prognostic factors (predicting the likely course of the disease) and predictive factors (predicting response to specific treatments).
  13. Quality Assurance:

    • Oncopathologists play a role in quality assurance, ensuring accurate and standardized reporting of pathology results.

Oncopathology is integral to cancer diagnosis, treatment planning, and research. Advances in molecular techniques and personalized medicine have significantly enhanced the role of Oncopathology in tailoring cancer treatments to individual patients. If you have specific questions or if there's a particular aspect you'd like more information on, feel free to ask.

DM - Oncology

Certainly, let's discuss Oncology. Oncology is the medical specialty focused on the prevention, diagnosis, and treatment of cancer. Oncologists are physicians who specialize in oncology and work in collaboration with other healthcare professionals to provide comprehensive care for cancer patients. Here are key aspects of Oncology:

  1. Prevention:

    • Oncologists emphasize preventive measures to reduce the risk of developing cancer. This may include lifestyle modifications, vaccination (e.g., HPV vaccine for cervical cancer prevention), and screening programs.
  2. Cancer Diagnosis:

    • Oncologists use various diagnostic tools, including imaging studies, biopsies, and laboratory tests, to accurately diagnose and stage cancer.
  3. Tumor Boards:

    • Multidisciplinary tumor boards bring together oncologists, surgeons, radiologists, pathologists, and other specialists to discuss and collaboratively plan the best treatment approach for individual cancer cases.
  4. Treatment Planning:

    • Oncologists develop personalized treatment plans based on the type and stage of cancer, as well as the patient's overall health. Treatment modalities may include surgery, chemotherapy, radiation therapy, immunotherapy, hormone therapy, targeted therapy, or a combination of these.
  5. Surgical Oncology:

    • Surgical oncologists specialize in the surgical management of cancer. They perform biopsies, tumor removals, and other surgical procedures to treat or diagnose cancer.
  6. Medical Oncology:

    • Medical oncologists focus on the use of systemic therapies such as chemotherapy, immunotherapy, targeted therapy, and hormone therapy to treat cancer.
  7. Radiation Oncology:

    • Radiation oncologists use radiation therapy to target and destroy cancer cells. This may involve external beam radiation or internal radiation (brachytherapy).
  8. Hematology-Oncology:

    • Hematologist-oncologists specialize in the treatment of blood cancers, such as leukemia, lymphoma, and myeloma, as well as other hematological disorders.
  9. Palliative Care:

    • Palliative care specialists work in conjunction with oncologists to provide supportive care and improve the quality of life for patients with advanced or terminal cancer.
  10. Clinical Trials:

    • Oncologists may recommend participation in clinical trials to explore new and innovative treatments, contributing to advancements in cancer care.
  11. Genomic Medicine:

    • Advances in genomics allow oncologists to analyze the genetic makeup of tumors, guiding treatment decisions and identifying targeted therapies.
  12. Cancer Survivorship:

    • Oncologists provide ongoing care and support for cancer survivors, addressing long-term effects of treatment and monitoring for potential recurrence.
  13. End-of-Life Care:

    • Oncologists, along with palliative care specialists, assist patients and their families in making decisions about end-of-life care and providing compassionate support.
  14. Patient Education:

    • Oncologists play a crucial role in educating patients about their diagnosis, treatment options, and potential side effects, empowering them to make informed decisions about their care.

Oncology is a rapidly evolving field with ongoing research and advancements aimed at improving outcomes for cancer patients. If you have specific questions about oncology or if there's a particular aspect you'd like more information on, feel free to ask.